Cite
Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome
MLA
Ortiz S, et al. Impact of Azacitidine on Red Blood Cell Alloimmunisation in Myelodysplastic Syndrome. Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..0d5bb9c6e2767275f8071caa1403eb07&authtype=sso&custid=ns315887.
APA
Ortiz S, Orero M, Javier K, Villegas C, Luna I, Perez P, Roig M, Lopez M, Costa S, Carbonell F, Collado R, Ivars D, & Linares M. (2017). Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome.
Chicago
Ortiz S, Orero M, Javier K, Villegas C, Luna I, Perez P, Roig M, et al. 2017. “Impact of Azacitidine on Red Blood Cell Alloimmunisation in Myelodysplastic Syndrome,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..0d5bb9c6e2767275f8071caa1403eb07&authtype=sso&custid=ns315887.